Abstract

BackgroundCentral venous (CV) port is an integral part of chemotherapy and parenteral treatment, for long-term venous access. It is still unclear whether there is a correlation between venipuncture sites, and complications and patency of the CV port placed in the chest wall. MethodsTwo-hundred and sixty-nine patients, who underwent CV port placement in their chest wall, were reviewed retrospectively in this study. They were divided into two groups, the S (subclavian vein) group and I (internal jugular vein) group, according to the venipuncture site. We analyzed the data from the medical records and examined the differences in complications between the two groups. ResultsThe median event free period among all patients was 228 days (range: 5–1877), the cumulative follow-up period was 97,176 catheter days. There were no significant differences between the two groups in terms of sex, age, body mass index (BMI), primary disease, reason for implant, past history of diabetes mellitus and occurrence of procedural complications. The median event free days were 200.0 (6–1846) in the S group and 246.0 (5–1877) days in the I group. The rate of event-free port availability after one, two and three years was 84.6, 74.0 and 66.5% in the S group, and 84.4, 80.3 and 80.3% in the I group respectively, which were not significantly different between the two groups. ConclusionsComplications of CV port placement have no correlation with the subclavian or jugular vein puncture sites.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.